Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
13.01
-0.11 (-0.84%)
Oct 29, 2025, 10:42 AM EDT - Market open
Carlsmed Revenue
Carlsmed had revenue of $12.08M in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $38.27M. In the year 2024, Carlsmed had annual revenue of $27.17M with 97.16% growth.
Revenue (ttm)
$38.27M
Revenue Growth
+97.16%
P/S Ratio
1.47
Revenue / Employee
$430,000
Employees
89
Market Cap
345.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.17M | 13.39M | 97.16% |
| Dec 31, 2023 | 13.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCARL News
- 5 days ago - Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025 - GlobeNewsWire
- 4 weeks ago - Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary - GlobeNewsWire
- 5 weeks ago - Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index - GlobeNewsWire
- 2 months ago - UPDATE - Carlsmed® Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Carlsmed® Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025 - GlobeNewsWire
- 3 months ago - Carlsmed's aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures - GlobeNewsWire
- 3 months ago - Carlsmed's aprevo® Powers First Personalized Cervical Spine Surgery - GlobeNewsWire